By The promising results come after the jab was trialled in the UK and South Africa. Novavax said 15,000 people aged between 18 and 84 had enrolled in its trial in the UK. The pharmaceutical firm said it expects to use the results to apply for a regulatory review in Britain, the European Union and...
Fight against Covid: New vaccine reports nearly 90% effective in Phase 3 of trial
from Newslanes https://ift.tt/2MzXZg5
0 comments:
Post a Comment